On 20-21 April, Bayer, ESTEVE, Roche and 180 leading industry players shared their strategies for sustainability, digitalisation, patient centricity and anti-counterfeiting at PHARMAP 2026 in Amsterdam. 

What insights were shared at PHARMAP 2026:

 

Live technology demonstrations:

BWT Pharma & Biotech demonstarted their AQU@Sense MB – water bioburden analyser designed to deliver rapid and precise microbiological analysis of water in the pharmaceutical industry.

Identiv demonstrated their NFC, HF, BLE and UHF innovations in action.

 

Anti-counterfeiting measures:

Nina Zehetmaier, Head of Sales at Securikett, explored modular security concepts that includes tamper evidence, security printing, secure UID, NFC integrator and anticloning to prevent counterfeiting.

 

 

Digitalisation strategies:

Markus Hartung, Vice President Region EMEA & Global Commercial Processes at Evonik operations GmbH, presents Evonik’s NextGen Technologies platform, which unites global expertise in process technology, engineering, product stewardship, energy solutions and safety

 

 

These are only part of the insights explored – the business programme for 2027 promises to bring even more expert insights with proven ROI.

Why PHARMAP became the key event for the industry in 2026?

 

In 2027, PHARMAP will bring industry expertise to Berlin, the event will be held in partnership and host sponsorship of Bayer AG.